Kiora PharmaceuticalsKPRX

13F holders, Q2 2025 (June 30)
16holders −2
2new positions
4sold out
$2.88avg. 13F price*

At the end of Q2 2025, 16 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, down 2 from Q1 2025. 2 opened new positions and 4 sold out. The largest holders were AIGH Capital Management LLC ($623K), Nantahala Capital Management, LLC ($608K) and Stonepine Capital Management, LLC ($513K).

Company
Kiora Pharmaceuticals Inc.
CUSIP
49721T507
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q2 2024: 15Q2 2024Q3 2024: 18Q3 2024Q4 2024: 16Q4 2024Q1 2025: 18Q1 2025Q2 2025: 16Q2 2025Q3 2025: 17Q3 2025Q4 2025: 19Q4 2025Q1 2026: 18Q1 2026Q2 2026: 22Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions2$107
Exits4$850K

All 13F filers, Q1 2025 → Q2 2025: 17,906 shares bought and 371,466 shares sold, net −353,560 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 16 holders

AIGH Capital Management LLC 0.29% Reduce -14.7% 216,345 $623K
Nantahala Capital Management, LLC 0.04% No change 211,110 $608K
Stonepine Capital Management, LLC 0.51% Reduce -11.3% 178,000 $513K
ADAR1 Capital Management, LLC 0.08% Reduce -14.2% 167,111 $481K
Velan Capital Investment Management LP 0.35% No change 122,223 $352K
Geode Capital Management, LLC 0.00% Add +1.2% 18,573 $53K
UBS Group AG 0.00% Add +882100.0% 17,644 $51K
Tower Research Capital LLC (TRC) 0.00% Reduce -79.9% 439 $1K
SBI Securities Co., Ltd. 0.00% No change 256 $737
BlackRock, Inc. 0.00% No change 58 $167
Citigroup Inc. 0.00% New 35 $101
NewEdge Advisors, LLC 0.00% No change 22 $63
Bank of America Corp. 0.00% Add +5.0% 21 $61
Raymond James Financial Inc. 0.00% New 2 $6
Activest Wealth Management 0.00% No change 2 $6
Osaic Holdings, Inc. 0.00% No change 2 $5

"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.